XFOR

Conviction 61HealthcareScan · Thu, Jun 25, 2026

XFOR$4.00-2.20%

ResistanceSupportVol 14Insider sell

Vol MA14 562.76K

Mar 26Apr 14May 1May 19Jun 8Jun 25

X4 Pharmaceuticals, IncBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.x4pharma.com ↗

Price4.00

Change-2.20%

Gap-0.12%

Rel volume3.08×

Avg volume533.77K

Avg $ vol2.15M

SMA 204.01

SMA 504.09

SMA 2003.78

Price vs 50-2.21%

Price vs 200+5.91%

MA stackmixed

50/200 cross—

Supertrenddown · 4.35

RSI (14)49

MACD hist0.02

MACD crossbull · 7d

Stoch %K / %D44 / 48

ADX (14)16

+DI / −DI22 / 16

RSI divergence—

MACD divergence—

ATR %+5.66%

ADR %5.51%

52w high4.66

52w low1.42

From 52w high-14.16%

Above 52w low+181.69%

New 52w highNo

SqueezeOn · 7d

Bollinger width14.68%

%B0.48

Donchian pos44.44%

Donchian high4.43

Donchian low3.66

AVWAP (52w high)3.80

vs AVWAP high+5.29%

AVWAP (52w low)3.12

vs AVWAP low+28.06%

OBV trendFlat

Chaikin MF (20)-0.12

Today vs 20d3.08×

Avg vol (14d)562.76K

Avg vol (20d)533.77K

Avg $ vol (20d)2.15M

Market cap377.28M

RS 3m (vs SPY)-5.19%

RS 6m (vs SPY)+5.88%

RS line new highNo

Trend template6/8

Technical rank43.7

1 week-1.23%

1 month+0.00%

3 months-2.20%

6 months-2.44%

1 year+73.91%

YTD+2.83%

P/E-4.76

P/B2.24

P/S10.74

P/FCF-4.39

EPS-1.87

Div yield—

ROE-47.02%

ROA-29.30%

Debt/Eq0.32

Current10.18

EV/EBITDA-2.51

Gross margin—

Net margin-225.55%

Rev growth1273.21%

EPS growth-111.48%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value214.94M

Revenue2.71M

Net income-20.24M

Gross profit—

Free cash flow-85.94M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out94.32M

Employees45

ListedThu, Nov 16, 2017

Free float88.8M

Float %94.2%

Short interest3.37M

Days to cover9.3d

Short volume60.1%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction61 / 100

Pattern quality—

Tech rank43.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.51

Support3.61

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XFOR

All disclosures →

No recent disclosed trades by Congress in XFOR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XFOR · 1 sell

Insider	Side	Shares	Value	Traded	Filed
KIRSKE DAVID Chief Financial Officer · Common Stock · 2026-05-12	Sell	16.96K	$73K	2026-05-12	2026-05-13

SEC filings

EDGAR filings in XFOR

EDGAR →

No recent SEC filings on file for XFOR.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.